REQUEST A DEMO
Total
USD $0.00
Search more companies

Wpd Pharmaceuticals Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Wpd Pharmaceuticals Sp. z o.o. Profile Updated: July 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Wpd Pharmaceuticals Sp. z o.o. is based in Poland, with the head office in Warsaw. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. Wpd Pharmaceuticals Sp. z o.o. was incorporated on September 01, 2017. From the latest financial highlights, Wpd Pharmaceuticals Sp. z o.o. reported a net sales revenue increase of 39.13% in 2023. Its’ total assets recorded a growth of 25.23%.

Headquarters
Ul. Zwirki I Wigury 101
Warsaw; Mazowieckie; Postal Code: 02-089

Contact Details: Purchase the Wpd Pharmaceuticals Sp. z o.o. report to view the information.

Website: http://www.wpdpharmaceuticals.eu/

Basic Information
Outstanding Shares:
Purchase the Wpd Pharmaceuticals Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Wpd Pharmaceuticals Sp. z o.o. report to view the information.
Incorporation Date:
September 01, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Wpd Pharmaceuticals Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
39.13%
Total operating revenue
86.6%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
25.23%
Total equity
N/A
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
-30.58%
Quick Ratio
12.81%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?